The effect of New oxygenation device on respiratory function enhancment.

The prevention effect of new oxygenation device versus nasal cannula in increasing exhalation co2

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210216050379N3

Enrollment

200

Registered

2022-05-15

Start date

2022-05-10

Completion date

Unknown

Last updated

2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The preventive effect of new oxygenation device versus nasal canulla in increasing exhalation Co2. ????? ?? ?????? ????

Interventions

Intervention 1: Intervention group: Patients in intervention group (A) receive 4 liters per minute of oxygen by a new oxygenation device that is sterile, reusable and washable. The polylactic acid wei

Eligibility

Sex/Gender

All

Age

30 Years to 70 Years

Inclusion criteria

Inclusion criteria: Local blepharoplasty surgery via intravenous sedation

Exclusion criteria

Exclusion criteria: Chronic pulmonary, cardiovascular, renal, hepatic dysfunction or psychiatric disorders. Sever chest wall deformity. Patients without the possibility of cooperation such as language problems or deafness.

Design outcomes

Primary

Measure	Time frame
Measurement of End tidal co2 and peripheral oxygen saturation. Timepoint: IN 0, 5, 10, 15, 20, 25, 30, 35, 40, 50, 60, 70, 80, 90 minutes. Method of measurement: Capnography and Pulse oximetery device.	—

Secondary

Measure	Time frame
Respiratory Rate. Timepoint: In 0, 5, 10, 15, 20, 25, 30, 35, 40, 50, 60, 70, 80 and 90 minutes. Method of measurement: Inspection ,counting the number of inhales and exhales in the mentioned minutes.;Blood pressure. Timepoint: In 0, 5, 10, 15, 20, 25, 30, 35, 40, 50, 60, 70, 80, 90 minutes. Method of measurement: Sphygmomanometer (non invasive).;Agitation and restlessness. Timepoint: In 0, 5, 10,15, 20, 25, 30, 35, 40, 50, 60, 70, 80, 90 minutes. Method of measurement: Richmond Agitation -sedation Questionnaire.	—

Measure

Time frame

Respiratory Rate. Timepoint: In 0, 5, 10, 15, 20, 25, 30, 35, 40, 50, 60, 70, 80 and 90 minutes. Method of measurement: Inspection ,counting the number of inhales and exhales in the mentioned minutes.;Blood pressure. Timepoint: In 0, 5, 10, 15, 20, 25, 30, 35, 40, 50, 60, 70, 80, 90 minutes. Method of measurement: Sphygmomanometer (non invasive).;Agitation and restlessness. Timepoint: In 0, 5, 10,15, 20, 25, 30, 35, 40, 50, 60, 70, 80, 90 minutes. Method of measurement: Richmond Agitation -sedation Questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamidreza Azizifarsani

Shahid Beheshti University of Medical Sciences

h.faresani@gmail.com+98 21 2238 2080

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026